Healthcare provider profile · identity verified

Babak Iranmanesh, MD

Family Practice · BARBERTON, OH · NPI 1760636492

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	746	223
Amlodipine Besylate	Amlodipine Besylate	358	104
Levothyroxine Sodium	Levothyroxine Sodium	352	100
Lisinopril	Lisinopril	335	95
Losartan Potassium	Losartan Potassium	295	84
Simvastatin	Simvastatin	285	67
Omeprazole	Omeprazole	190	58
Rosuvastatin Calcium	Rosuvastatin Calcium	181	62
Metformin Hcl Er	Metformin Hcl	177	48
Eliquis	Apixaban	167	39
Metoprolol Succinate	Metoprolol Succinate	151	45
Gabapentin	Gabapentin	148	48
Hydrochlorothiazide	Hydrochlorothiazide	137	41
Metformin Hcl	Metformin Hcl	137	40
Carvedilol	Carvedilol	133	30
Tamsulosin Hcl	Tamsulosin Hcl	126	38
Pravastatin Sodium	Pravastatin Sodium	125	37
Sertraline Hcl	Sertraline Hcl	123	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	113	27
Fluticasone Propionate	Fluticasone Propionate	112	41
Finasteride	Finasteride	107	34
Jardiance	Empagliflozin	103	28
Montelukast Sodium	Montelukast Sodium	98	25
Alendronate Sodium	Alendronate Sodium	96	31
Famotidine	Famotidine	89	25
Trazodone Hcl	Trazodone Hcl	89	26
Trulicity	Dulaglutide	89	18
Escitalopram Oxalate	Escitalopram Oxalate	87	28
Tramadol Hcl	Tramadol Hcl	76	18
Xarelto	Rivaroxaban	74	15
Alprazolam	Alprazolam	71	22
Allopurinol	Allopurinol	67	21
Furosemide	Furosemide	66	23
Atenolol	Atenolol	65	14
Ezetimibe	Ezetimibe	65	19
Duloxetine Hcl	Duloxetine Hcl	64	20
Bupropion Hcl Sr	Bupropion Hcl	61	20
Synthroid	Levothyroxine Sodium	61	15
Donepezil Hcl	Donepezil Hcl	58	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	58	16
Ozempic	Semaglutide	56	21
Lorazepam	Lorazepam	52	16
Spironolactone	Spironolactone	50	18
Albuterol Sulfate Hfa	Albuterol Sulfate	45	32
Glipizide Er	Glipizide	45	13
Azelastine Hcl	Azelastine Hcl	44	19
Pantoprazole Sodium	Pantoprazole Sodium	43	17
Zolpidem Tartrate	Zolpidem Tartrate	43	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	42	11
Baclofen	Baclofen	42	14
Hydralazine Hcl	Hydralazine Hcl	42	suppressed
Warfarin Sodium	Warfarin Sodium	42	13
Clopidogrel	Clopidogrel Bisulfate	38	11
Fluoxetine Hcl	Fluoxetine Hcl	38	12
Glimepiride	Glimepiride	38	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	14
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Meclizine Hcl	Meclizine Hcl	31	13
Propranolol Hcl	Propranolol Hcl	31	12
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Memantine Hcl Er	Memantine Hcl	27	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Buspirone Hcl	Buspirone Hcl	25	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Prednisone	Prednisone	25	22
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Doxepin Hcl	Doxepin Hcl	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	20
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Lovastatin	Lovastatin	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Azithromycin	Azithromycin	16	15
Bumetanide	Bumetanide	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Unifine Pentips	Pen Needle, Diabetic	15	suppressed
Dutasteride	Dutasteride	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Potassium Chloride	Potassium Chloride	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Torsemide	Torsemide	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Naproxen	Naproxen	12	12
Nifedipine Er	Nifedipine	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Valsartan	Valsartan	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	11
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error